Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.10.0.1
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2018
Stockholders' Equity [Abstract]  
Schedule of changes in stockholders' equity

 

                Additional           Total  
    Common Stock     paid-in     Accumulated     stockholders’  
    Shares     Amount     capital     deficit     equity  
Balance at December 31, 2017     6,340,604     $ 6     $ 36,202     $ (31,844 )   $ 4,364  
Net proceeds from sale of common stock     271,520       -       466       -       466  
Net proceeds from private sale of stock     806,452       1       977               978  
Stock-based compensation expense     -       -       140       -       140  
Issuance of restricted stock options     55,147       -       55               55  
Net loss     -       -       -       (3,158 )     (3,158 )
Balance at September 30, 2018     7,473,723     $ 7     $ 37,840     $ (35,002 )   $ 2,845  
 
Schedule of periodical gross proceeds from private placements

 

          Gross  
Date   Shares     Proceeds  
April 29, 2018     806,452 (1)   $ 1,000  
April 4 – April 23, 2018     131,225 (2)     176  
January 19, 2018     140,295 (3)     296  
February 8, 2017     500,000 (4)     2,125  

 

(1) Shares issued pursuant to a private placement with accredited investors for $1.24 per share.
(2) Shares of common stock sold for between $1.25 and $1.38 per share in an at-the-market offering.
(3)  Shares of common stock sold for $2.111 per share in an at-the-market offering.
(4) Shares issued pursuant to a registered direct offering with an institutional investor for $4.25 per share.